Teva inhaler approved; Oxford to create center for drug delivery devices;

> Teva ($TEVA) received FDA approval for its Qvar inhaler with a dose counter to treat asthma. Release

> Oxford University announced plans for a new research center, The Oxford Centre for Drug Delivery Devices. Release

> Equashield announced FDA clearance of its eponymous first and second generation closed systems to minimize exposure to hazardous drugs. Release

> FDA agreed to review Mallinckrodt's ($MNK) New Drug Application for its extended-release oral formulation of hydrocodone and acetaminophen for pain management. Release